Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership36,315 shares
Latest Disclosed Value $ 18,351,422
Jpmorgan Chase & Co ownership in YDO1 / Madrigal Pharmaceuticals, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 36,315 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $16,352,644 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 40,079 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -9.39% during the quarter. The current value of the position is $15,477,453 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (YDO1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:YDO1 / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 36,315 -3,764 -9.39 18,351 -21.37 0.0001
2026-05-13 2026-03-31 13F MADRIGAL PHARMACEUTICALS IN COMMON 558868105 0 -100.00 0
2026-02-11 2025-12-31 13F MADRIGAL PHARMACEUTICALS IN COMMON 558868105 40,079 -7,745 -16.19 23,340 6.41 0.0015
2025-11-26 2025-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 47,824 -8,030 -14.38 21,935 29.76 0.0013
2025-11-07 2025-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 47,824 -8,030 21,935 0.0001
2025-08-12 2025-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 55,854 27,840 99.38 16,904 82.16 0.0011
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 28,014 -36,221 -56.39 9,279 -53.18 0.0007
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 64,235 -6,543 -9.24 19,821 31.96 0.0015
2024-12-26 2024-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 70,778 18,122 34.42 15,021 1.82 0.0011
2024-11-08 2024-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 70,778 18,122 15,021 0.0011
2024-12-26 2024-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 52,656 -2,748 -4.96 14,752 -0.29 0.0012
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 52,656 -2,748 14,752 0.0012
2024-12-26 2024-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 55,404 -3,909 -6.59 14,795 7.81 0.0012
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 55,404 -3,909 14,795 0.0013
2024-12-26 2023-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 59,313 -39,144 -39.76 13,724 -4.56 0.0013
2024-02-12 2023-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 59,313 -39,144 13,724 0.0013
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 98,457 10,166 11.51 14,379 -29.50 0.0016
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 88,291 34,849 65.21 20,395 57.53 0.0022
2023-05-18 2023-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 53,442 -984 -1.81 12,947 86,213.33 0.0016
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 37,726 -16,700 10,584 0.0002
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 54,426 18,094 49.80 16 -99.36 0.0021
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 36,332 -3,467 -8.71 2,361 -17.13 0.0003
2022-08-11 2022-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 39,799 4,125 11.56 2,849 -18.60 0.0004
2022-05-11 2022-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 35,674 1,017 2.93 3,500 19.21 0.0004
2022-02-11 2021-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 34,657 -1,251 -3.48 2,936 2.48 0.0003
2022-02-10 2021-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 34,657 -1,251 2,936 0.0003
2021-11-12 2021-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 35,908 28,451 381.53 2,865 294.09 0.0004
2021-08-12 2021-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 7,457 2,016 37.05 727 14.13 0.0001
2021-05-12 2021-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 5,441 1,469 36.98 637 44.12 0.0001
2021-02-19 2020-12-31 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 3,972 711 21.80 442 13.62 0.0001
2021-02-11 2020-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 3,972 711 442 10.9310
2020-11-12 2020-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 3,261 308 10.43 389 16.47 0.0001
2020-11-12 2020-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 3,261 389
2020-08-11 2020-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,953 37 1.27 334 71.28 0.0001
2020-05-12 2020-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,916 378 14.89 195 -15.58 0.0000
2020-02-11 2019-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,538 -24 -0.94 231 4.52 0.0000
2019-11-12 2019-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,562 416 19.38 221 2.31 0.0000
2019-08-07 2019-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,146 461 27.36 216 2.37 0.0000
2019-05-07 2019-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 1,685 -388,810 -99.57 211 -99.52 0.0000
2019-02-11 2018-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 390,495 388,788 22,776.10 44,017 11,959.45 0.0102
2018-11-13 2018-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COMMON 558868105 1,707 -18,422 -91.52 365 -93.52 0.0001
2018-11-07 2018-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 1,707 -18,422 365
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 20,129 -14,922 -42.57 5,630 37.52 0.0012
2018-05-10 2018-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 35,051 34,055 3,419.18 4,094 4,398.90 0.0009
2018-02-13 2017-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 996 -6,031 -85.83 91 -72.00 0.0000
2017-11-09 2017-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 7,027 7,027 325 0.0001
2017-08-09 2017-06-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 0 -2,907 -100.00 0 -100.00
2017-05-10 2017-03-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,907 819 39.22 45 45.16 0.0000
2017-02-06 2016-12-31 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 2,088 2,000 2,272.73 31 3,000.00 0.0000
2016-11-04 2016-09-30 13F MADRIGAL PHARMACEUTICALS COMMON 558868105 88 88 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 22,600 -41.30 6,974 -14.65 n/a n/a n/a
2024-12-26 2024-09-30 13F/A MADRIGAL PHARMACEUTICALS OPTION Call 38,500 -9.62 8,170 -31.54 n/a n/a n/a
2024-11-08 2024-09-30 13F MADRIGAL PHARMACEUTICALS OPTION Call 38,500 8,170 n/a n/a n/a
2024-12-26 2024-06-30 13F/A MADRIGAL PHARMACEUTICALS OPTION Call 42,600 -29.24 11,935 -25.76 n/a n/a n/a
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS OPTION Call 42,600 11,935 n/a n/a n/a
2024-12-26 2024-03-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Call 60,200 29.46 16,076 49.41 n/a n/a n/a
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 60,200 16,076 n/a n/a n/a
2024-12-26 2023-12-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Call 46,500 -36.73 10,759 0.24 n/a n/a n/a
2024-02-12 2023-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 46,500 10,759 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS OPTION Call 73,500 -82.44 10,734 -88.90 n/a n/a n/a
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS OPTION Call 418,600 -0.64 96,697 -5.26 n/a n/a n/a
2023-05-18 2023-03-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Call 421,300 4,113.00 102,064 5,103,100.00 n/a n/a n/a
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 421,300 102,064 n/a n/a n/a
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 10,000 3 n/a n/a n/a
2019-08-07 2019-06-30 13F MADRIGAL PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-07 2019-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 27,000 200.00 3,382 233.53 n/a n/a n/a
2019-02-11 2018-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Call 9,000 1,014 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 900 -94.34 278 -91.79 n/a n/a n/a
2024-12-26 2024-09-30 13F/A MADRIGAL PHARMACEUTICALS OPTION Put 15,900 0.00 3,374 -24.25 n/a n/a n/a
2024-11-08 2024-09-30 13F MADRIGAL PHARMACEUTICALS OPTION Put 15,900 3,374 n/a n/a n/a
2024-12-26 2024-06-30 13F/A MADRIGAL PHARMACEUTICALS OPTION Put 15,900 1,666.67 4,455 1,755.83 n/a n/a n/a
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS OPTION Put 15,900 4,455 n/a n/a n/a
2024-12-26 2024-03-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Put 900 240 n/a n/a n/a
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 900 240 n/a n/a n/a
2024-12-26 2023-12-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-12 2023-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 0 0 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS OPTION Put 115,700 -53.01 16,897 -70.29 n/a n/a n/a
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS OPTION Put 246,200 4.06 56,872 -0.78 n/a n/a n/a
2023-05-18 2023-03-31 13F/A MADRIGAL PHARMACEUTICALS OPTION Put 236,600 653.50 57,319 636,777.78 n/a n/a n/a
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 236,600 57,319 n/a n/a n/a
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS OPTION Put 31,400 -64.36 9 -99.84 n/a n/a n/a
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS OPTION Put 88,100 5,726 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.